FDA Actions Anger House

October 7, 1996

FDA Actions Anger House

The FDA's refusal to grant marketing approval for a home drug- testing device is drawing fire from the House Commerce Committee. At a hearing late last week, the committee won a pledge from FDA officials that the agency will not take regulatory action against Sunny Cloud, a woman who has been marketing a home drug test without FDA approval. But the same day, the agency sent a letter to Cloud's lawyer reiterating its position that the test is a Class III device requiring extensive review for approval. During the hearing, committee members questioned the Class III designation when the agency does not regulate drug tests in the workplace.

Commerce Chairman Bliley and other committee members the next day denounced the agency's action, and FDA Commissioner David Kessler went to Capitol Hill for an impromptu meeting with the committee at which he gave written and oral assurances the agency would take no action against Cloud until it completes a review of its designation of home drug test kits as Class III devices. Bliley also demanded the agency give him a list of the people involved in the incident by Monday of this week, and said he would demand resignations at the agency. Bliley Tuesday said he has not received an adequate response.

FDA official Bruce Burlington told the committee at the hearing the agency gave the test a Class III designation because it requires home diagnostic tests to have the highest reliability ratings. FDA spokesman Jim O'Hara told CongressDaily that home tests for HIV, glucose and cholesterol all have Class III designations. However, during questioning, FDA officials raised issues of the potential of the device for creating family discord, and said workplace tests are not regulated because they are administered by professionals. Committee members accused the agency of showing paternalistic attitudes toward parents concerned about possible drug use by their children. Cloud's test requires a urine sample to be mailed to a drug testing laboratory for analysis by laboratory professionals.

The Christian Science Monitor Thursday quoted White House Drug Czar Barry McCaffrey as saying home drug testing is not a "magic bullet" for preventing teen drug use, but that parents should have the option of using the tests. FDA's O'Hara said the agency has no problem with the concept of home testing for drugs, but it wants to make sure consumers have accurate information and that the tests are adequately labelled for their intended use. In addition, some approved Class III home diagnostic tests require lab analysis and some give the consumer immediate results, O'Hara said. FDA's main objection to Cloud's device is that she has been marketing it without agency approval, he said. The "Aware" home drug test kit is available under prescription with FDA approval, but the agency has denied approval for over-the-counter sales.

Stay up-to-date with federal news alerts and analysis — Sign up for GovExec's email newsletters.
Close [ x ] More from GovExec

Thank you for subscribing to newsletters from GovExec.com.
We think these reports might interest you:

  • Sponsored by G Suite

    Cross-Agency Teamwork, Anytime and Anywhere

    Dan McCrae, director of IT service delivery division, National Oceanic and Atmospheric Administration (NOAA)

  • Data-Centric Security vs. Database-Level Security

    Database-level encryption had its origins in the 1990s and early 2000s in response to very basic risks which largely revolved around the theft of servers, backup tapes and other physical-layer assets. As noted in Verizon’s 2014, Data Breach Investigations Report (DBIR)1, threats today are far more advanced and dangerous.

  • Sponsored by One Identity

    One Nation Under Guard: Securing User Identities Across State and Local Government

    In 2016, the government can expect even more sophisticated threats on the horizon, making it all the more imperative that agencies enforce proper identity and access management (IAM) practices. In order to better measure the current state of IAM at the state and local level, Government Business Council (GBC) conducted an in-depth research study of state and local employees.

  • Sponsored by Aquilent

    The Next Federal Evolution of Cloud

    This GBC report explains the evolution of cloud computing in federal government, and provides an outlook for the future of the cloud in government IT.

  • Sponsored by LTC Partners, administrators of the Federal Long Term Care Insurance Program

    Approaching the Brink of Federal Retirement

    Approximately 10,000 baby boomers are reaching retirement age per day, and a growing number of federal employees are preparing themselves for the next chapter of their lives. Learn how to tackle the challenges that today's workforce faces in laying the groundwork for a smooth and secure retirement.

  • Sponsored by Hewlett Packard Enterprise

    Cyber Defense 101: Arming the Next Generation of Government Employees

    Read this issue brief to learn about the sector's most potent challenges in the new cyber landscape and how government organizations are building a robust, threat-aware infrastructure

  • Sponsored by Aquilent

    GBC Issue Brief: Cultivating Digital Services in the Federal Landscape

    Read this GBC issue brief to learn more about the current state of digital services in the government, and how key players are pushing enhancements towards a user-centric approach.


When you download a report, your information may be shared with the underwriters of that document.